Menu
Back to User profile » Dr Sherief Abd-Elsalam
Papers published by Dr Sherief Abd-Elsalam:
Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease
Mohamed AA, Abo-Elmatty DM, Ezzat O, Mesbah NM, Ali NS, Abd El Fatah AS, Alsayed E, Hamada M, Hassnine AA, Abd-Elsalam S, Abdelghani A, Hassan MB, Fattah SA
Diabetes, Metabolic Syndrome and Obesity 2022, 15:1935-1943
Published Date: 22 June 2022
Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study
Abo-Amer YEE, Sabal A, Ahmed R, Hasan NFE, Refaie R, Mostafa SM, Mohamed AA, Khalil M, Elagawy W, Abd-Elsalam S
Diabetes, Metabolic Syndrome and Obesity 2020, 13:619-625
Published Date: 2 March 2020
Serum Dickopff 1 as a Novel Biomarker in Hepatocellular Carcinoma Diagnosis and Follow Up After Ablative Therapy
Younis YS, Alegaily HS, Elagawy W, Semeya AA, Abo-Amer YEE, El-Abgeegy M, Mostafa SM, Elsergany HF, Abd-Elsalam S
Cancer Management and Research 2019, 11:10555-10562
Published Date: 17 December 2019
Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt
Saleh AM, Hassan EA, Gomaa AA, El Baz TM, El-Abgeegy M, Seleem MI, Abo-amer YEE, Elsergany HF, Mahmoud EIED, Abd-Elsalam S
Infection and Drug Resistance 2019, 12:2277-2282
Published Date: 24 July 2019
Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia
Elbedewy TA, Elsebaey MA, Elshweikh SA, Elashry H, Abd-Elsalam S
Therapeutics and Clinical Risk Management 2019, 15:269-274
Published Date: 11 February 2019
Declining prevalence of hepatitis C virus among university students in one of the main governorates in Egypt
Abo-Amer YE, Abd-Elsalam S, Eldosoky H, ELShenawy AK, Awny S, Elagawy W, El Abgeegy M, Elsergany HF, Elashry H, Negm MS
Infection and Drug Resistance 2018, 11:2435-2441
Published Date: 22 November 2018
Metformin ameliorated methotrexate-induced hepatorenal toxicity in rats in addition to its antitumor activity: two birds with one stone
Rizk FH, El Saadany AA, Dawood L, Elkaliny HH, Sarhan NI, Badawi R, Abd-Elsalam S
Journal of Inflammation Research 2018, 11:421-429
Published Date: 8 November 2018
Copeptin as a novel marker predicting prognosis of liver cirrhosis and its major complications
Tawfik AK, Helmy A, Yousef M, Abou-Saif S, Kobtan A, Asaad E, Abd-Elsalam S
Hepatic Medicine: Evidence and Research 2018, 10:87-93
Published Date: 4 September 2018
IL-1α correlates with severity of hepatitis C virus-related liver diseases
Tawfik AK, Amin AM, Yousef M, El-sayd NM, Elashry H, Elkadeem M, Abd-Elsalam S
Journal of Inflammation Research 2018, 11:289-295
Published Date: 10 July 2018
Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection
Ahmed OA, Elsebaey MA, Fouad MHA, Elashry H, Elshafie AI, Elhadidy AA, Esheba NE, Elnaggar MH, Soliman S, Abd-Elsalam S
Infection and Drug Resistance 2018, 11:441-445
Published Date: 28 March 2018
Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection
Ahmed OA, Kaisar HH, Badawi R, Hawash N, Samir H, Shabana SST, Fouad MHA, Rizk FH, Khodeir SA, Abd-Elsalam S
Infection and Drug Resistance 2018, 11:295-298
Published Date: 1 March 2018
A novel scoring system for prediction of esophageal varices in critically ill patients
Hanafy AS, Badawi R, Basha MAA, Selim A, Yousef M, Elnawasany S, Mansour L, Elkhouly RA, Hawash N, Abd-Elsalam S
Clinical and Experimental Gastroenterology 2017, 10:315-325
Published Date: 7 December 2017